HOME
A-Z

Fulvestrant Injection

Fulvestrant is a hormonal treatment for metastatic breast cancer. It is suitable for postmenopausal women with progression following other hormonal therapy.

What is this medication used for

Fulvestrant is a hormonal treatment for metastatic breast cancer. It is suitable for postmenopausal women with progression following other hormonal therapy.

Dosage and How to Use

It is given once a month as an intramuscular injection in the buttock.

Side Effects, Precautions, Contraindication

What are the side effects of Fulvestrant?

Nausea and vomiting

Bone and back pain

May be relieved by taking paracetamol

Abdominal pain

Headache and dizziness may occur

Fatigue

Hot flushes may occur

Sore throat

Pain at injection site

Inform your doctor if any of the following occurs:

Persistent bone and back pain

Chest pain and rapid, irregular heartbeat

Swelling of extremities

Unusual weight gain (>3kg/week)

Cough with difficulty breathing

Painful or burning urination

Other persistent or severe side effects

Handling and Storage

Keep it in the refrigerator between 2 - 8°C. Do not freeze.

Additional Information

Other name: Faslodex^®

If you have any questions, please call your pharmacist at the National Cancer Centre. The side effects listed above are those that occur frequently. Other side effects may occur. Please contact your doctor to report.

Disclaimer: The National Cancer Centre Singapore does not endorse or promote the use of any product mentioned in this booklet. The information is presented in a summary to provide an understanding and for knowledge only, and may not contain information about all aspects of care. It does not recommend self-management of health problems or replace consultation with your doctor. You should never disregard medical advice or delay seeking treatment because of something you have read in this booklet.

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission from the publisher.

Document No. PHM-MED-PEM-093/0916